We are live on !
Find out more
Bailard Portfolio holdings
AUM
$4.94B
Turnover
24.33%
1-Year Est. Return
25.15%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+25.15%
3 Year Est. Return
+104.94%
5 Year Est. Return
+121.63%
10 Year Est. Return
+438.61%
AUM
$4.94B
AUM Growth
+$29M
(+0.59%)
Cap. Flow
-$36.1M
Cap. Flow % of AUM
Cap. Flow %
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
32.74%
Holding
859
New
96
Increased
235
Reduced
231
Closed
113
Avg Time Held
4
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
4.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$73.8M |
| 2 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$47.7M |
| 3 |
Vanguard California Tax-Exempt Bond ETF
VTEC
|
+$13.9M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$11.6M |
| 5 |
NVIDIA
NVDA
|
+$6.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$73.3M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$44M |
| 3 |
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
|
+$15.8M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$12.8M |
| 5 |
Vanguard ESG US Stock ETF
ESGV
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.17% |
| 2 | Technology | 25.16% |
| 3 | Financials | 7.27% |
| 4 | Healthcare | 6.82% |
| 5 | Communication Services | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
DELISTED
Simulations Plus
SLP
| $184K | ﹤0.01% |
10,000
| – | – |
2026 Q1
2 quarters
|
|
727
Puma Biotechnology
PBYI
$527M
| $180K | ﹤0.01% |
18,100
| – | – |
2026 Q1
2 quarters
|
|
728
Protalix BioTherapeutics
PLX
$206M
| $169K | ﹤0.01% |
61,100
| – | – |
2026 Q2
1 quarter
|
|
729
Rayonier Advanced Materials
RYAM
$465M
| $163K | ﹤0.01% |
+20,405
| New | +$171K |
2026 Q3
0 quarters
|
|
730
Zevra Therapeutics
ZVRA
$603M
| $161K | ﹤0.01% |
14,700
| – | – |
2025 Q4
3 quarters
|
|
731
QuantumScape Corp
QS
$2.41B
| $158K | ﹤0.01% |
34,100
| – | – |
2022 Q4
15 quarters
|
|
732
Oramed Pharmaceuticals
ORMP
$169M
| $152K | ﹤0.01% |
32,478
| – | – |
2026 Q1
2 quarters
|
|
733
Artiva Biotherapeutics
ARTV
$288M
| $147K | ﹤0.01% |
20,700
| – | – |
2026 Q1
2 quarters
|
|
734
Shoe Station Group
SHOE
$368M
| $132K | ﹤0.01% |
+10,300
| New | +$149K |
2026 Q3
0 quarters
|
|
735
Airgain
AIRG
$52.4M
| $126K | ﹤0.01% |
+25,400
| New | +$141K |
2026 Q3
0 quarters
|
|
736
Climb Bio
CLYM
$559M
| $125K | ﹤0.01% |
10,900
| – | – |
2026 Q2
1 quarter
|
|
737
Cytek Biosciences
CTKB
$682M
| $119K | ﹤0.01% |
19,900
| – | – |
2025 Q3
4 quarters
|
|
738
Compass
COMP
$6.92B
| $118K | ﹤0.01% |
+13,300
| New | +$151K |
2026 Q3
0 quarters
|
|
739
ImmuCell
ICCC
$95.5M
| $99K | ﹤0.01% |
10,102
| – | – |
2026 Q1
2 quarters
|
|
740
Arbutus Biopharma
ABUS
$838M
| $87.5K | ﹤0.01% |
+18,314
| New | +$88.3K |
2026 Q3
0 quarters
|
|
741
Atea Pharmaceuticals
AVIR
$352M
| $83.9K | ﹤0.01% |
16,100
| – | – |
2026 Q2
1 quarter
|
|
742
Ideal Power
IPWR
$48.2M
| $80K | ﹤0.01% |
20,365
| – | – |
2022 Q4
15 quarters
|
|
743
Fulcrum Therapeutics
FULC
$283M
| $74.4K | ﹤0.01% |
+20,100
| New | +$75.4K |
2026 Q3
0 quarters
|
|
744
Neuberger High Yield Strategies Fund Inc
NHS
$222M
| $58.7K | ﹤0.01% |
10,839
| – | – |
2021 Q3
20 quarters
|
|
745
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$967M
| $49.3K | ﹤0.01% |
20,300
-13,800
| -40% | -$32.9K |
2026 Q2
1 quarter
|
|
746
SurgePays
SURG
$6.19M
| $4.2K | ﹤0.01% |
27,975
| – | – |
2023 Q2
13 quarters
|
|
747
ACI Worldwide
ACIW
$5.27B
| – | – |
-10,700
| Closed | -$538K | – |
|
748
Aecom
ACM
$7.47B
| – | – |
-4,080
| Closed | -$285K | – |
|
749
American Electric Power
AEP
$67.9B
| – | – |
-1,566
| Closed | -$214K | – |
|
750
Allegiant Air
ALGT
$1.81B
| – | – |
-4,686
| Closed | -$551K | – |
|
Similar funds
SL
FC
Bailard's Q3 2026 Portfolio in Review
As of Q3 2026, Bailard held 859 positions worth $4.94B, up 0.59% from $4.91B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bailard's Q3 2026 filing shows 96 new, 235 increased, 231 reduced and 113 closed positions. Its largest new stake was Assurant: 10,146 shares worth $2.67M. The largest sale was Invesco QQQ Trust, an estimated $73.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 42% a quarter earlier, followed by Technology and Financials.
- Bailard's largest Q3 2026 buy was Assurant: 10,146 shares worth $2.67M.
- Bailard added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $73.8M increase.
- Bailard's biggest Q3 2026 reduction was Invesco QQQ Trust, cutting an estimated $73.3M.
- Bailard fully exited Sunbelt Rentals Holdings in Q3 2026, selling an estimated $4.49M.
- Bailard's ten largest holdings make up 33% of its $4.94B portfolio in Q3 2026.
- Bailard opened 96 new positions and closed 113 in Q3 2026.
- Bailard's portfolio value rose 0.59% quarter-over-quarter to $4.94B.
Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.